Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis

Seckin U., Ozoran K., İKİNCİOĞULLARI K. A., Borman P., Bostan E.

RHEUMATOLOGY INTERNATIONAL, vol.19, no.5, pp.203-204, 2000 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 19 Issue: 5
  • Publication Date: 2000
  • Doi Number: 10.1007/s002960000054
  • Journal Name: RHEUMATOLOGY INTERNATIONAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.203-204
  • Keywords: hydroxychloroquine, ototoxicity, MIDDLE-EAR FUNCTION, CHLOROQUINE
  • Ankara University Affiliated: Yes

Abstract

We report a case of reversible sensineural hearing loss due to hydroxychloroquine (HQ) treatment. The patient was a 34-year-old woman with 1 year of rheumatoid arthritis (RA), She developed reversible hearing loss after 5 months of HQ treatment. Sensineural deafness has previously been reported with chloroquine treatment, but this is the first report of ototoxicity associated with HQ in RA.